Pevion Biotech

Bern, Switzerland Founded: 2001 • Age: 25 yrs
Develops vaccines for infectious diseases using virosome technology; ceased operations in 2013.

About Pevion Biotech

Pevion Biotech was a Healthcare company based in Bern (Switzerland) founded in 2001. It develops vaccines for infectious diseases using virosome technology; ceased operations in 2013. It operates on a B2B model. Pevion Biotech has raised $29.4 million across 1 funding round from investors including BB Biotech Ventures. The company is recorded as dissolved. Its focus areas include Biotechnology, Vaccines Development and Infectious Diseases.

Company details

Pevion Biotech, established in 2001, excels in providing healthcare solutions, advancing biotech innovations, vaccines development, and infectious diseases. Develops vaccines for infectious diseases using virosome technology; ceased operations in 2013. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

  • Headquarters Bern, Switzerland
  • Sectors
    Healthcare
  • Website pevion.com
Operational Areas
Key Metrics
  • Total Equity Funding
    $29.4M (USD)

    in 1 rounds

  • Latest Funding Round
    $29.4M (USD), Series A

    Aug 2007

  • Investors

Funding Insights of Pevion Biotech

Pevion Biotech has successfully raised a total of $29.4M through 1 strategic funding round. The most recent funding activity was a Series A round of $29.4 million completed in August 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $29.4M
  • Total Rounds 1
  • Last Round Series A β€” $29.4M
  • First Round $29.4M

    (Aug 2007)

  • Investors Count 1

All 1 funding rounds of Pevion Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2007$29.4MSeries A––
Valuation history

1 investors in total: 1 institutional.

Investors in Pevion Biotech

Pevion Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BB Biotech Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
bbbiotechventures.com
Premium access

Investor details for Pevion Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Pevion Biotech

2 dated milestones of Pevion Biotech across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pevion Biotech is founded.
  2. Funding First funding round of $29.4M.

Web traffic of Pevion Biotech

Websites that share an audience with Pevion Biotech (pevion.com).

Similar websites

Websites whose visitors overlap most with Pevion Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
polyphor.com
39%
View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pevion Biotech

Premium access

Complete news archive for Pevion Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pevion Biotech

Pevion Biotech was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Pevion Biotech is headquartered in Bern, Switzerland. It is registered at Bern, Bern, Switzerland.

Pevion Biotech is a funded company, having raised a total of $29.4M across 1 funding round to date. The company's 1st funding round was a Series A of $29.4M, raised on Aug 2007.

Pevion Biotech, established in 2001, excels in providing healthcare solutions, advancing biotech innovations, vaccines development, and infectious diseases. Develops vaccines for infectious diseases using virosome technology; ceased operations in 2013. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Pevion Biotech has 1 investor. Key investors include BB Biotech Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available